Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain
Medtronic plc, a global healthcare technology leader, today announced its intent to acquire SPR Therapeutics, Inc.
Search fresh public links, source activity, and ready-to-use post angles for Spr Therapeutics.
Fresh curated links around SPR Therapeutics are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Medtronic plc, a global healthcare technology leader, today announced its intent to acquire SPR Therapeutics, Inc.
Medtronic has entered a deal to acquire SPR Therapeutics, a Cleveland-based company whose flagship product delivers short-term electrical nerve stimulation for chronic pain patient...
Acquisition will enhance Medtronic’s Neuromodulation portfolio with temporary peripheral nerve stimulation (PNS) technology, enabling earlier intervention for chronic…
By Pat AnsonScientists in Abu Dhabi have developed a tiny neuromodulation device that can treat chronic nerve pain without the need for invasive surgery. The experimental device is...
Three randomized controlled trials plus three case series — all looking at peripheral nerve stimulation as
Springs Health introduces innovative non-invasive brain stimulation technology designed to support mental wellness, cognitive performance, and emotional health without medication o...
The inventors of sustained acoustic medicine unveil advancements in the clinically validated, FDA-cleared device that revolutionizes recovery from soft-tissue injuries for athletes...
In a pivotal stride toward advancing therapeutic technology, a team of researchers has unveiled a revolutionary wireless electrical stimulation platform that promises to transform...
SpinaFX Medical's prospective, randomized, multicenter trial will compare intradiscal ozone/oxygen injection plus nerve root block to nerve root block alone in 300 patients in up t...
At the National Athletic Trainers Association meeting, the inventors of sam® showcase the clinically validated, FDA-cleared device that revolutionizes recovery from soft-tissue inj...
The company's SPY002 prompted a 10.7-point reduction from baseline levels in patients’ Robart’s Histopathology Index (RHI) scores by week 12.
The prospective, randomized, multicenter trial will compare intradiscal ozone/oxygen injection plus nerve root block to nerve root block…
A wearable bioelectronic device increased REM sleep in real-world trials without invasive surgery or medication. A restless night can leave more than fatigue behind. REM sleep play...
FDA-cleared, growth-friendly spinal implant developed in the Netherlands marks its U.S. clinical debut in a child with early-onset…
New carpal tunnel study from Sonex Health and The Institute of Advanced Ultrasound Guided Procedures of six-month data demonstrating the safety and efficacy of ultrasound-guided ca...
Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion’s AI-driven platform for chronic low back pain. Program…
Neurovalens’ Modius Spero has become the first FDA-approved neuromodulation device for treating PTSD symptoms. Veterans are set to gain access through the VA this summer. The post...
By Louise BurgessAn estimated 595 million people globally are living with osteoarthritis. This makes it one of the leading causes of pain and disability.Osteoarthritis is a degener...
Pacira BioSciences offloaded its cold-therapy pain relief device to medtech orthopedics specialist Zimmer Biomet in a deal valued at up to $140 million.
Veteran-founded MedTech pioneer aligns with non-profit to bridge the medical "Care Cliff" for stroke, SCI, MS, amputees, and individuals facing complex neurological conditions whil...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.